Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicus Pharma Ltd. Director's Dealing 2024

Dec 31, 2024

34562_dirs_2024-12-31_6c4e089e-116f-4fc7-88cb-bcbfcd4e4244.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31

Reporting Person: Raju Ajay (10% Owner)
Reporting Person: 215 Capital TOGO PHL Fund I, LP (10% Owner)
Reporting Person: Togo PHL Management LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 2000000 Indirect

Footnotes

F1: The shares are held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein.